NI-57 * DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE PERFUSION WEIGHTED IMAGING (DCE-MRI) AND DIFFUSION WEIGHTED IMAGING (DWI) FOR PHARMACODYNAMIC EVALUATION OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) AND TEMOZOLOMIDE IN MALIGNANT GLIOMA | Zendy

Rajiv Magge | Zendy; Julio ArévaloPérez | Zendy; Robert J. Young | Zendy; Thomas Kaley | Zendy; Elena Pentsova | Zendy; Lisa M. DeAngelis | Zendy; Eli L. Diamond | Zendy; I. Mellinghoff | Zendy; Kyung K. Peck | Zendy; Barry Anderson | Zendy; Greg Gorman | Zendy; S. McLean | Zendy; Rashida A. Karmali | Zendy; Antonio Omuro | Zendy

Open Access

NI-57 * DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE PERFUSION WEIGHTED IMAGING (DCE-MRI) AND DIFFUSION WEIGHTED IMAGING (DWI) FOR PHARMACODYNAMIC EVALUATION OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) AND TEMOZOLOMIDE IN MALIGNANT GLIOMA

Author(s) -

Rajiv Magge,

Julio ArévaloPérez,

Robert J. Young,

Thomas Kaley,

Elena Pentsova,

Lisa M. DeAngelis,

Eli L. Diamond,

I. Mellinghoff,

Kyung K. Peck,

Barry Anderson,

Greg Gorman,

S. McLean,

Rashida A. Karmali,

Antonio Omuro

Publication year - 2014

Publication title -

neuro-oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.005

H-Index - 125

eISSN - 1523-5866

pISSN - 1522-8517

DOI - 10.1093/neuonc/nou264.55

Subject(s) - medicine , temozolomide , magnetic resonance imaging , glioma , effective diffusion coefficient , nuclear medicine , diffusion mri , perfusion , bevacizumab , imaging biomarker , radiology , chemotherapy , cancer research

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research